World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT01331629
Date of registration: 05/04/2011
Prospective Registration: No
Primary sponsor: Centre Francois Baclesse
Public title: Impact of Art Therapy on Fatigue and Quality of Life of Patients Treated With Adjuvant Radiotherapy for Breast Cancer ART-THERAPIE
Scientific title: Impact of Art Therapy on Fatigue and Quality of Life of Patients Treated With Adjuvant Radiotherapy for Breast Cancer
Date of first enrolment: July 2010
Target sample size: 322
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01331629
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).  
Phase:  Phase 2/Phase 3
Countries of recruitment
France
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Breast cancer surgery (invasive or in situ) by conservative surgery

- Age = 18 years

- Indication of adjuvant radiotherapy

- Adjuvant chemotherapy allowed

- Agreeing to participate in a clinical study

- Able to participate in a clinical trial

Exclusion Criteria:

- Metastatic Breast Cancer

- Personal history of breast cancer



Age minimum: 18 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Breast Cancer
Intervention(s)
Other: ART-THERAPIE
Primary Outcome(s)
evaluate persistent fatigue [Time Frame: up to 12 months after radiotherapy]
Secondary Outcome(s)
Evaluate the anxiety of patients [Time Frame: up 12 months after radiotherapy]
evaluate the depression of patients [Time Frame: up 12 months after study]
Evaluate the quality of life away from the treatment (at 6 months and 1 year) of patients [Time Frame: 6 months and 1 year after treatment]
Assess the impact of the condition of patients on the reactions, depression and anxiety of relatives Assess the impact of the condition of patients on the reactions, depression and anxiety of relatives [Time Frame: up to 12 months after radiotherapy]
Evaluate the quality of life patients. [Time Frame: up to 12 months after radiotherapy]
Evaluate the fatigue away from the treatment (at 6 months and 1 year) of patients [Time Frame: 6 months and 12 months after treatment]
Secondary ID(s)
ART-THERAPIE
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ligue contre le cancer, France
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history